Free Trial

Forian (FORA) Expected to Announce Earnings on Thursday

Forian logo with Medical background
Remove Ads

Forian (NASDAQ:FORA - Get Free Report) will likely be announcing its earnings results after the market closes on Thursday, March 27th. Analysts expect the company to announce earnings of $0.02 per share and revenue of $5.37 million for the quarter.

Forian Trading Down 5.5 %

Shares of FORA traded down $0.12 during trading hours on Friday, reaching $2.06. The company had a trading volume of 8,903 shares, compared to its average volume of 16,428. The firm has a 50 day simple moving average of $2.30 and a 200-day simple moving average of $2.17. The company has a market capitalization of $63.89 million, a price-to-earnings ratio of -22.89 and a beta of 1.06. Forian has a 12-month low of $1.96 and a 12-month high of $4.03.

Insider Activity

In other Forian news, CEO Max C. Wygod acquired 12,320 shares of the stock in a transaction that occurred on Tuesday, February 11th. The shares were purchased at an average cost of $2.67 per share, with a total value of $32,894.40. Following the purchase, the chief executive officer now owns 1,324,500 shares in the company, valued at approximately $3,536,415. The trade was a 0.94 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 31.30% of the company's stock.

About Forian

(Get Free Report)

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.

Recommended Stories

Earnings History for Forian (NASDAQ:FORA)

Should You Invest $1,000 in Forian Right Now?

Before you consider Forian, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Forian wasn't on the list.

While Forian currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Quantum Stocks Are Heating Up Again — 7 to Watch Now

Quantum Stocks Are Heating Up Again — 7 to Watch Now

After a brief dip earlier this year, fresh momentum has reignited interest; from penny plays to tech giants, these quantum stocks could lead the next surge.

Related Videos

Quantum Stocks Are Heating Up Again — 7 to Watch Now
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads